Announcement on Notifying Creditors of Registered Capital Reduction
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Notifying Creditors of Registered Capital Reduction
Filed with SSE · · 2 pages · Chinese
Release
Zhejiang CONBA Pharmaceutical Co., Ltd. on 6ix
Earlier from Zhejiang CONBA Pharmaceutical
- Announcement on Implementation of Independent Exercise in the 2nd Exercise Period of Stock Options Initially Granted in 2022 Stock Option Incentive Plan
- Announcement on the Completion of Cancellation of Some Stock Options under the 2022 Stock Option Incentive Plan
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on Compliance with Exercise Conditions for the 1st Vesting Period of Stock Options Reserve Granted under 2022 Stock Option Incentive Plan
- Announcement on Resolutions of the 11th (Extraordinary) Meeting of the 11th Board of Directors
Later from Zhejiang CONBA Pharmaceutical
- Announcement on Resignation Matters of Chairman, Legal Representative and Other Personnel
- Announcement on Proposed Shareholding Increase Plan by the Controlling Shareholder Zhejiang Medicine Group through Block Trading
- Announcement on Propiverine Hydrochloride Inhalation Solution Obtaining Drug Registration Certificate by Subsidiary
- Announcement on Election of Chairman, Vice Chairman, and Other Matters
- Announcement on Voluntary Exercise Results of Stock Option Incentive Plan in Q4 2025 and Share Changes
Follow Zhejiang CONBA Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang CONBA Pharmaceutical